MDRX Key Statistics, Chart & Performance
The current stock price of MDRX is 6.81 USD. In the past month the price decreased by -27.55%. In the past year, price decreased by -54.9%.
MDRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 28.84 | 36.69B | ||
| DOCS | DOXIMITY INC-CLASS A | 27 | 8.34B | ||
| WAY | WAYSTAR HOLDING CORP | 24.44 | 6.27B | ||
| HTFL | HEARTFLOW INC | N/A | 2.48B | ||
| CERT | CERTARA INC | 17.62 | 1.40B | ||
| SDGR | SCHRODINGER INC | N/A | 1.32B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.24B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 638.5 | 1.08B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.06B | ||
| PHR | PHREESIA INC | N/A | 1.01B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.74 | 919.86M | ||
| CTEV | CLARITEV CORP | N/A | 706.66M |
Related stock screener links
About MDRX
Company Profile
Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. The company is headquartered in Chicago, Illinois and currently employs 8,000 full-time employees. The firm is focused on research, analytics, and building scalable data-driven solutions. The company combines data-driven clinical insights with actionable tools to enable healthcare stakeholders improve the value of healthcare delivery. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its Veradigm Network Solutions include Veradigm Real World Data, Veradigm Real World Evidence, Veradigm Digital Health Media, and Evalytica. Its health plan and payer solutions include eCHART COURIER, Veradigm Payer Insights, and Risk Adjustment & Quality Analytics. Its healthcare provider solutions include Veradigm Practice Management, Veradigm Payerpath, and Electronic Health Records. The company also provides full-service revenue cycle management.
Company Info
VERADIGM INC
222 Merchandise Mart Plaza, Suite 2024
Chicago ILLINOIS 60654 US
CEO: Paul M. Black
Employees: 8000
Phone: 13125061200
VERADIGM INC / MDRX FAQ
What does VERADIGM INC do?
Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. The company is headquartered in Chicago, Illinois and currently employs 8,000 full-time employees. The firm is focused on research, analytics, and building scalable data-driven solutions. The company combines data-driven clinical insights with actionable tools to enable healthcare stakeholders improve the value of healthcare delivery. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its Veradigm Network Solutions include Veradigm Real World Data, Veradigm Real World Evidence, Veradigm Digital Health Media, and Evalytica. Its health plan and payer solutions include eCHART COURIER, Veradigm Payer Insights, and Risk Adjustment & Quality Analytics. Its healthcare provider solutions include Veradigm Practice Management, Veradigm Payerpath, and Electronic Health Records. The company also provides full-service revenue cycle management.
What is the current price of MDRX stock?
The current stock price of MDRX is 6.81 USD. The price decreased by -10.39% in the last trading session.
What is the dividend status of VERADIGM INC?
MDRX does not pay a dividend.
How is the ChartMill rating for VERADIGM INC?
MDRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the sector and industry classification for VERADIGM INC?
VERADIGM INC (MDRX) operates in the Health Care sector and the Health Care Technology industry.
Can you provide the number of employees for VERADIGM INC?
VERADIGM INC (MDRX) currently has 8000 employees.
Who owns VERADIGM INC?
You can find the ownership structure of VERADIGM INC (MDRX) on the Ownership tab.
MDRX Technical Analysis
MDRX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MDRX Forecast & Estimates
12 analysts have analysed MDRX and the average price target is 13.99 USD. This implies a price increase of 105.41% is expected in the next year compared to the current price of 6.81.